|
ELTX Elicio Therapeutics Inc 1601485 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-8,217,000.00 |
| Balance Sheet |
|
Current Assets
|
$25,485,000.00 |
|
Assets
|
$31,330,000.00 |
|
Current Liabilities
|
$9,202,000.00 |
|
Liabilities
|
$23,393,000.00 |
|
Equity
|
$7,937,000.00 |
|
Shares Out
|
21901569.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-19,810,000.00 |
|
Investing Cash Flow
|
$-16,000.00 |
| Market Analysis |
Market Cap
|
$67,456,832.52 |
|
Price
|
$3.08 |
|
BVPS
|
0.36 |
|
PB
|
8.56 |
|
EPS
|
-0.43 |
|
FCF
|
$-19,826,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:51 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:42 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ELTX documents filed with the SEC.
ELTX Filings
Clear
